Pharmacologic pain treatment of musculoskeletal disorders: Current perspectives and future prospects

被引:63
|
作者
Curatolo, M
Bogduk, N
机构
[1] Univ Hosp Bern, Dept Anesthesiol, Div Pain Therapy, CH-3010 Bern, Switzerland
[2] Univ Newcastle, Bone & Joint Inst, Newcastle, NSW 2308, Australia
来源
CLINICAL JOURNAL OF PAIN | 2001年 / 17卷 / 01期
关键词
drug therapy; musculoskeletal pain;
D O I
10.1097/00002508-200103000-00005
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: The authors aimed to provide an educational update on the current evidence of the effectiveness of drug therapy in the treatment of musculoskeletal pain and to offer a perspective of possible future developments. Design: The authors used a pragmatic review of data provided by available systematic reviews and seminal controlled studies pertaining to the treatment of regional musculoskeletal pain problems. Results: Epidural steroids may offer limited, short-term benefit for sciatica. Local injections of steroids are either ineffective or provide short-lasting benefits. Nonsteroidal anti-inflammatory drugs and opioids reduce pain, but the effect size is modest. The literature does not support convincingly the use of antidepressants. Certain muscle relaxants may be useful in the treatment of back pain. Hyaluronic acid, neutraceutical agents, avocado-soybean unsaponifiable agents, oxaceprol and diacerein may be effective in the treatment of osteoarthritis, but the information regarding these new agents does not allow wholesale endorsement of these substances. Selective epidural injection of steroids at a target nerve root approached through the intervertebral foramin has the potential to replace the traditional epidural approach. Long-acting, C-fiber-specific local anesthetics are under investigation and could provide long-lasting pain relief without motor or sensory impairment. In the future, central hypersensitivity in chronic musculoskeletal pain might be treated using antagonists of the N-methyl-D-aspartate receptor. Cannabinoid agents produce antinociception and prevent experimentally induced hyperalgesia in animals, and they may find a role in pain management. Methods to optimize drug combinations are available. Conclusions: The effectiveness of the currently available drugs in the treatment of musculoskeletal pain conditions is disappointing. Recent developments may open new perspectives in this area of pain medicine.
引用
收藏
页码:25 / 32
页数:8
相关论文
共 50 条
  • [1] Future perspectives in generalised musculoskeletal pain syndromes
    Russell, I. Jon
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2011, 25 (02): : 321 - 331
  • [2] Biomarkers: current perspectives and future prospects
    Naylor, S
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2003, 3 (05) : 525 - 529
  • [3] Burdensome problems of chronic musculoskeletal pain and future prospects
    Ushida, Takahiro
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2015, 20 (06) : 958 - 966
  • [4] Extended duration strategies for the pharmacologic treatment of diabetic retinopathy: current status and future prospects
    Stewart, Michael W.
    Flynn, Harry W., Jr.
    Schwartz, Stephen G.
    Scott, Ingrid U.
    EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (09) : 1277 - 1287
  • [5] Current and Future Pharmacologic Treatment of Sarcopenia
    Rolland, Yves
    Onder, Graziano
    Morley, John E.
    Gillette-Guyonet, Sophie
    van Kan, Gabor Abelian
    Vellas, Bruno
    CLINICS IN GERIATRIC MEDICINE, 2011, 27 (03) : 423 - +
  • [6] Current Perspectives and Future Prospects of Nano-Biotechnology in Wastewater Treatment
    Sahu, J. N.
    Karri, Rama Rao
    Zabed, Hossain M.
    Shams, Shahriar
    Qi, Xianghui
    SEPARATION AND PURIFICATION REVIEWS, 2021, 50 (02): : 139 - 158
  • [7] FUTURE PERSPECTIVES FOR THE USE OF PRP IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS
    Sanchez, M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S92 - S92
  • [8] Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
    Sheehan, David V.
    Sheehan, Kathy Harnett
    PSYCHOPHARMACOLOGY BULLETIN, 2007, 40 (01) : 98 - 109
  • [9] Current and future pharmacologic treatment of nonalcoholic steatohepatitis
    Banini, Bubu A.
    Sanyal, Arun J.
    CURRENT OPINION IN GASTROENTEROLOGY, 2017, 33 (03) : 134 - 141
  • [10] The potential of xanthotoxin in the treatment of cognitive disorders: current insights and future perspectives
    Agarwal, Uma
    Pannu, Arzoo
    Tonk, Rajiv Kumar
    Jaiswal, Puja
    Jain, Kajal
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 10 (01)